Revolution Medicines Director Lorence H. Kim Sells $11.38M in Common Stock
Revolution Medicines, Inc.
Subscribe to track RVMD
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
📊 Insider Sale Alert: RVMD • Insider: Lorence H. Kim (Director) • Filing Date: 2026-09-02 • Transaction Date: 2026-08-31 • Type: Sale (Open Market, Rule 10b5-1) • Shares Sold: 56,000 • Avg Price: ~$203.24 • Total Value: ~$11,381,288 • Remaining Indirect Shares: 17,090 (plus 1,191 directly held) • Details: Executed under a Rule 10b5-1 plan adopted June 1, 2026 by the Lorence Kim Revocable Trust.
Comprehensive Analysis
Executive Summary
On August 31, 2026, Lorence H. Kim, a member of the Board of Directors of Revolution Medicines, Inc. ($RVMD), disposed of 56,000 shares of common stock held indirectly via the Lorence Kim Revocable Trust. The total transaction value amounted to approximately $11.38 million, executed at weighted-average prices ranging from $200.56 to $206.15 across multiple tranches.
Transaction Breakdown
- Date of Execution: 2026-08-31
- Security: Common Stock
- Transaction Code: S (Open Market Sale)
- Ownership Type: Indirect (Lorence Kim Revocable Trust)
- Volume & Prices:
- 300 shares @ $200.56
- 6,597 shares @ $201.4729
- 12,919 shares @ $202.4819
- 26,160 shares @ $203.5483
- 7,271 shares @ $204.3501
- 2,128 shares @ $205.1879
- 625 shares @ $206.1540
- Aggregate Shares Sold: 56,000 shares
- Total Gross Proceeds: $11,381,287.59
Ownership Structure & Plan Details
- Pre-Transaction Holdings (Trust): 73,090 shares
- Post-Transaction Holdings (Trust): 17,090 shares (~76.6% reduction in trust holdings)
- Direct Ownership: 1,191 shares (consisting of restricted stock units)
- Rule 10b5-1 Plan: Transactions were executed pursuant to a pre-arranged Rule 10b5-1 trading plan established on June 1, 2026.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.